Suppr超能文献

相似文献

3
Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
Hum Gene Ther. 2001 May 1;12(7):811-21. doi: 10.1089/104303401750148766.
4
Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.
Mol Ther. 2011 Jan;19(1):67-75. doi: 10.1038/mt.2010.209. Epub 2010 Sep 28.
7
Gene therapy of lung adenocarcinoma using herpes virus expressing a fusogenic membrane glycoprotein.
Cell Biochem Biophys. 2014 Jul;69(3):583-7. doi: 10.1007/s12013-014-9836-4.

引用本文的文献

1
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
Mol Ther. 2024 Jul 3;32(7):2406-2422. doi: 10.1016/j.ymthe.2024.05.014. Epub 2024 May 11.
2
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Nat Commun. 2023 May 26;14(1):3035. doi: 10.1038/s41467-023-38651-x.
3
Concepts in Oncolytic Adenovirus Therapy.
Int J Mol Sci. 2021 Sep 29;22(19):10522. doi: 10.3390/ijms221910522.
4
Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.
Cancer Gene Ther. 2021 Aug;28(7-8):745-756. doi: 10.1038/s41417-020-0192-9. Epub 2020 Jul 1.
5
Syncytia Formation in Oncolytic Virotherapy.
Mol Ther Oncolytics. 2019 Oct 1;15:131-139. doi: 10.1016/j.omto.2019.09.006. eCollection 2019 Dec 20.
6
An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate .
Mol Ther Oncolytics. 2019 May 15;14:107-120. doi: 10.1016/j.omto.2019.05.001. eCollection 2019 Sep 27.
7
Oncolytic viruses: overcoming translational challenges.
J Clin Invest. 2019 Mar 4;129(4):1407-1418. doi: 10.1172/JCI122287.
8
Fusogenic Viruses in Oncolytic Immunotherapy.
Cancers (Basel). 2018 Jun 26;10(7):216. doi: 10.3390/cancers10070216.
10
Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.
Mol Ther. 2011 Jan;19(1):67-75. doi: 10.1038/mt.2010.209. Epub 2010 Sep 28.

本文引用的文献

2
Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway.
Mol Ther. 2007 Sep;15(9):1607-15. doi: 10.1038/sj.mt.6300239. Epub 2007 Jun 19.
6
Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.
Cancer Gene Ther. 2005 Apr;12(4):341-9. doi: 10.1038/sj.cgt.7700801.
9
Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer.
Cancer Res. 2004 May 1;64(9):3265-70. doi: 10.1158/0008-5472.can-03-3753.
10
Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
J Neurooncol. 2003 Dec;65(3):237-46. doi: 10.1023/b:neon.0000003653.45635.32.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验